Evaluation of IBI302 Injection in nAMD or DME

Clinical trial NCT05961007 · SUSPENDED

Trial details

NCT number: NCT05961007
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration Diabetic Macular Edema

Start date: 2021-11-18
Primary completion: 2023-10-31
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.